Athira Pharma
Dr. Lon Schneider directs the USC State of California Alzheimer’s Disease Center and the USC National Institute on Aging Alzheimer’s Disease Research Center clinical core. He served as a senior scientific advisor at the NIMH, on the American Psychiatric Association Committee for Practice Guidelines in Alzheimer’s and Other Dementia, the World Federation of Societies of Biological Psychiatry Task Force on Dementia.
He holds a master’s degree in biometry and epidemiology and has expertise in clinical trials methods and drug development. His work involves treatment development with novel metabolic and neuroregenerative compounds, outcomes assessment, and approaches to modeling and clinical trials simulations.
He is an associate editor or editorial board member of several publications, including the Cochrane Dementia and Cognitive Improvement Group, Current Alzheimer Research, BMC-Psychiatry, Alzheimer’s & Dementia, The Lancet Neurology, and Clinical Neuropharmacology among others; is editor-in-chief of Alzheimer’s & Dementia: Translational Research and Clinical Interventions; and has authored numerous papers and chapters.
This person is not in the org chart
This person is not in any offices
Athira Pharma
1 followers
Athira's aim is to restore neuronal health for those suffering from neurological diseases, including Alzheimer’s, so that patients can regain their memories, lives, and family relationships.